» Articles » PMID: 32397911

COVID-19 Pandemic: an Overview of Epidemiology, Pathogenesis, Diagnostics and Potential Vaccines and Therapeutics

Overview
Journal Ther Deliv
Date 2020 May 14
PMID 32397911
Citations 72
Authors
Affiliations
Soon will be listed here.
Abstract

At the time of writing this review, severe acute respiratory coronavirus syndrome-2 (SARS-CoV-2) has infected more than 2,355,853 patients and resulted in more than 164,656 deaths worldwide (as of 20 April 2020). This review highlights the preventive measures, available clinical therapies and the potential of vaccine development against SARS-CoV-2 by taking into consideration the strong genetic similarities of the 2003 epidemic SARS-CoV. Recent studies are investigating the repurposing of US FDA-approved drugs as there is no available vaccine yet with many attempts under clinical evaluation. Several antivirals, antimalarials and immunomodulators that have shown activity against SARS-CoV and Middle East coronavirus respiratory syndromes are being evaluated. In particular, hydroxychloroquine, remdesivir, favipiravir, arbidol, tocilizumab and bevacizumab have shown promising results. The main aim of this review is to provide an overview of this pandemic and where we currently stand.

Citing Articles

Therapeutic proteins: developments, progress, challenges, and future perspectives.

Kumar V, Barwal A, Sharma N, Mir D, Kumar P, Kumar V 3 Biotech. 2024; 14(4):112.

PMID: 38510462 PMC: 10948735. DOI: 10.1007/s13205-024-03958-z.


Assessing Functional Cognition and Health During COVID-19 Pandemic: Gender Differences Among Community-Dwelling Adults.

Josman N, Atiya Y, Dagan T, Issa E, Demeter N J Prim Care Community Health. 2023; 14:21501319231218801.

PMID: 38097506 PMC: 10725103. DOI: 10.1177/21501319231218801.


COVID-19 knowledge, attitude, and preventive practices among government and private bank workers in Ethiopia.

Hassen S, Adane M Front Public Health. 2023; 11:1251701.

PMID: 38026278 PMC: 10643604. DOI: 10.3389/fpubh.2023.1251701.


Fear, Anxiety and Depression among Bosnia and Herzegovina Citizens during the Third Wave of COVID-19.

Sljivo A, Kulenovic A Iran J Psychiatry. 2023; 18(1):1-10.

PMID: 37159641 PMC: 10163905. DOI: 10.18502/ijps.v18i1.11407.


Potential treatments of COVID-19: Drug repurposing and therapeutic interventions.

Raghav P, Mann Z, Ahluwalia S, Rajalingam R J Pharmacol Sci. 2023; 152(1):1-21.

PMID: 37059487 PMC: 9930377. DOI: 10.1016/j.jphs.2023.02.004.


References
1.
Woo P, Huang Y, Lau S, Yuen K . Coronavirus genomics and bioinformatics analysis. Viruses. 2011; 2(8):1804-1820. PMC: 3185738. DOI: 10.3390/v2081803. View

2.
Zheng X, Tao G, Zhang Y, Yang G, Huang P . [Drug interaction monitoring of lopinavir/ritonavir in COVID-19 patients with cancer]. Zhonghua Nei Ke Za Zhi. 2020; 59(5):400-404. DOI: 10.3760/cma.j.cn112138-20200219-00097. View

3.
Al Johani S, Hajeer A . MERS-CoV diagnosis: An update. J Infect Public Health. 2016; 9(3):216-9. PMC: 7102781. DOI: 10.1016/j.jiph.2016.04.005. View

4.
Ammad Ud Din M, Boppana L . An update on the 2019-nCoV outbreak. Am J Infect Control. 2020; 48(6):713. PMC: 7102631. DOI: 10.1016/j.ajic.2020.01.023. View

5.
Kelly-Cirino C, Mazzola L, Chua A, Oxenford C, Van Kerkhove M . An updated roadmap for MERS-CoV research and product development: focus on diagnostics. BMJ Glob Health. 2019; 4(Suppl 2):e001105. PMC: 6361340. DOI: 10.1136/bmjgh-2018-001105. View